BioSenic S.A.
BioSenic S.A. (BIOS.BR) Company Profile & Overview
Explore BioSenic S.A.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
BioSenic S.A. (BIOS.BR) Company Profile & Overview
BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures. The company is based in Mont-Saint-Guibert, Belgium.